Director, Oncology CPMS AI/ML Modelling Leader in Stevenage

Director, Oncology CPMS AI/ML Modelling Leader in Stevenage

Stevenage Full-Time 80000 - 100000 £ / year (est.) No working from home possible
1

At a Glance

  • Tasks: Lead AI/ML modelling in oncology and drive innovative strategies for clinical pharmacology.
  • Company: Join GSK, a leader in healthcare innovation and collaboration.
  • Benefits: Competitive salary, flexible working, and opportunities for professional growth.
  • Other info: Work in a dynamic environment with cross-functional teams and external partners.
  • Why this job: Make a real impact in oncology through cutting-edge AI/ML technologies.
  • Qualifications: Strong background in AI/ML and experience in oncology or clinical pharmacology.

The predicted salary is between 80000 - 100000 £ per year.

GSK is seeking a Director, Oncology Clinical Pharmacology MIDD AI/ML to lead model‑based development and AI/ML approaches in oncology CPMS, contributing to strategy and regulatory submissions.

The role requires strong collaboration across cross‑functional teams and external partners.

The position emphasizes delivering quantitative excellence to inform dose selection, trial design, and regulatory strategies, with on‑site presence 2–3 days per week in the Stevenage area.

#J-18808-Ljbffr

Director, Oncology CPMS AI/ML Modelling Leader in Stevenage employer: 1925 GlaxoSmithKline LLC

At Closet America, a proud part of the Renuity family, we offer an exceptional work environment that fosters innovation and creativity. Our employees enjoy flexible schedules, comprehensive training, and ongoing support, ensuring personal and professional growth. Located in Raleigh, NC, our team thrives on collaboration and motivation, making it a rewarding place to build a meaningful career.

1

Contact Details:

1925 GlaxoSmithKline LLC Recruitment Team

We think you need these skills to ace Director, Oncology CPMS AI/ML Modelling Leader in Stevenage

AI/ML Modelling
Oncology Expertise
Model-Based Development
Quantitative Excellence
Dose Selection
Trial Design
Regulatory Submissions